Akyso Therapeutics, LLCFederal contracts and grants
- Saint Petersburg, FL
- UEI WMJ6UFULU731
USAspending shows $13M in obligations to this recipient in 3 of the 5 fiscal years from FY2023 to FY2027.
The obligations in FY2026 were $5.6M.
The obligations in FY2027 to date are under $1 million.
The awards of $1 million or more that started since FY2023 came from 1 agency.
The largest award value came from the Department of Health and Human Services.
A fiscal year under $1 million is not in the total.
The states where the work of the awards of $1 million or more is done. The swatches go from the smallest award value to the largest. The largest is Maryland: $13M.
Florida: the address of the recipient.
The amounts for each state. Outlines: US Census Bureau.
An outlay occurs when federal money is actually paid out, not just promised to be paid ("obligated").
Procurement data (such as for contracts and indefinite delivery vehicles (IDV)) for the Department of Defense (DOD) and U.S. Army Corps of Engineers (USACE) are published on a 90-day delay in the Federal Procurement Data System (FPDS).
Maintaining data quality for the award description field has been persistently challenging for federal agencies.
These are the words of USAspending. Sources: USAspending.gov, About the Data (PDF, last updated 19 November 2025) and USAspending.gov, Glossary. The site copied them on .
The amounts on this page are obligations. An obligation is a promise to pay. It is not a payment. Contract records of the Department of Defense come late, so a recent month can be low. The text under a name in a list of awards is the description that the agency wrote.
USAspending loaded the data on . USAspending profile of this recipient
Since the last update
No change is on record for this page.
The site compares each data load with the load before it. It records a change of the FY2027 obligations when the change is $1 million or more and 10% or more. It also records each new award of $1 million or more.
Obligations by fiscal year
| Fiscal year | All obligations | Contracts | Other awards |
|---|---|---|---|
| FY2023 | under $1 million | ||
| FY2024 | $1.8M | under $1 million | $1.8M |
| FY2025 | $5.6M | under $1 million | $5.6M |
| FY2026 | $5.6M | under $1 million | $5.6M |
| FY2027 to date | under $1 million |
Contracts are the procurement award types. Other awards are grants, direct payments, loans (subsidy cost) and other assistance. The contracts figure shows only when contracts alone are $1 million or more.
Awarding agencies
| Agency | Awards | Award value | Share |
|---|---|---|---|
| Department of Health and Human Services | 2 | $13M | 100% |
Awards
| Awarding agency | Type | Industry or program | Award value | Start date | Place | Record |
|---|---|---|---|---|---|---|
| Department of Health and Human ServicesNational Institutes of Health | GrantCooperative Agreement (B) | 93.279 Drug Use and Addiction Research Programs | $5.9M | 23 Jul 2025 | MD | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantCooperative Agreement (B) | 93.279 Drug Abuse and Addiction Research Programs | $7.2M | 9 May 2024 | MD | USAspending |
| Awarding agency | Type | Industry or program | Award value | Start date | Place | Record |
|---|---|---|---|---|---|---|
| Department of Health and Human ServicesNational Institutes of HealthA LONG-ACTING BIOABSORBABLE NALTREXONE SUBCUTANEOUS IMPLANT FOR OPIOID USE DISORDER - PROJECT SUMMARY/ABSTRACT THE OBJECTIVES FOR THIS PROPOSAL ARE (1) ... | GrantCooperative Agreement (B) | 93.279 Drug Abuse and Addiction Research Programs | $7.2M | 9 May 2024 | MD | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthDEVELOPMENT OF A BIOABSORBABLE, SUBCUTANEOUS, EXTENDED-RELEASE BUPRENORPHINE IMPLANT FOR OPIOID USE DISORDER - PROJECT SUMMARY/ABSTRACT THE DRUG DELIVERY ... | GrantCooperative Agreement (B) | 93.279 Drug Use and Addiction Research Programs | $5.9M | 23 Jul 2025 | MD | USAspending |
Industries, programs and places of performance
| Assistance listing | Awards | Award value |
|---|---|---|
| 93.279 Drug Use and Addiction Research Programs | 2 | $13M |
| State | Awards | Award value |
|---|---|---|
| Maryland | 2 | $13M |
The counties with the largest award value, largest first.
Other recipients of about the same size
Recipients of assistance listing 93.279, Drug Use and Addiction Research Programs, in all states. In order of name. These recipients have obligations nearest to those of Akyso Therapeutics, LLC in the listed fiscal years.
- Antidote Therapeutics IncSykesville, MD
- Baystate Medical Center, Inc.Springfield, MA
- Ensysce Biosciences, Inc.LA Jolla, CA
- Friends Research Institute, IncBaltimore, MD
- High Point UniversityHigh Point, NC
- Laureate Institute for Brain Research, Inc.Tulsa, OK
- Midwestern UniversityDowners Grove, IL
- Ndri-USA IncNew York, NY
- Nirsum Laboratories, Inc.New York, NY
- Research Foundation of the City University of New YorkFlushing, NY
- Sparian Biosciences IncNew York, NY
- Zetroz Systems LLCTrumbull, CT
All recipients in Florida, in order of name.
Official records
- USAspending profile of this recipientUSAspending.gov. The official record of the awards to this recipient (UEI WMJ6UFULU731).
- SAM.gov entity searchSAM.gov, U.S. General Services Administration. The search of entity registrations by name or UEI.
- USAspending advanced searchUSAspending.gov. The search of all award records, with filters for recipient, agency, place and time period.
Each link opens a page of a federal agency in a new tab. The site examined the links on .
Cite this page
Fed Spend Map. "Akyso Therapeutics, LLC: federal contracts and grants". Data: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, loaded .
https://fedspendmap.com/recipient/wmj6ufulu731-akyso-therapeutics-llc/
The address of this page is permanent.
Where the figures come from
USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service). Fiscal year obligations: the list of recipients by state, with a listing floor of $1 million for each year. Awards: the award search, new awards of $1 million or more by base obligation date. Parent and business types: the recipient profile.
USAspending loaded the data on 30 Sep 2026. A closed fiscal year is a copy made after the year end. The site shows organisations only. The site corrects an error in its own work at the next build. See how to report an error and how the atlas is made.
Questions
Which fiscal years are in the total?
The total has 3 fiscal years.
- FY2023: under $1 million
- FY2024: $1.8M
- FY2025: $5.6M
- FY2026: $5.6M
- FY2027 to date: under $1 million
The site lists a fiscal year of a recipient when the obligations of the year are $1 million or more.
Which industries and programs do the awards name?
The assistance awards name 1 assistance listing.
The largest award value is in listing 93.279, Drug Use and Addiction Research Programs: $13M.
Where is the place of performance?
The awards of $1 million or more name 1 state as the place of performance.
The largest award value is in Maryland: $13M.
The place of performance is where the work is done. It is not always the address of the recipient.
How many awards are in the lists on this page?
The lists hold 2 awards of $1 million or more that started in FY2023 or later.
Their award value is $13M.
An award under that amount is in the obligations of the fiscal years but not in the lists.